Table 1.
Demographic and clinical data of the patient cohorts.
| Clinical Characteristics | Values |
|---|---|
| Number of subjects, N (%) | 146 (100) |
| Age, mean (range) years | 46.2 (14–77) |
| Sex | |
| Male, N (%) | 88 (60) |
| Female, N (%) | 58 (40) |
| Hemisphere | |
| Left, N (%) | 95 (65) |
| Right, N (%) | 45 (31) |
| Bilateral, N (%) | 6 (4) |
| WHO grade | |
| 2, N (%) | 50 (34) |
| 3, N (%) | 50 (34) |
| 4, N (%) | 46 (32) |
| Molecular subtype | |
| Grade 2–3 diffuse astrocytoma, IDH-mutant, N (%) | 28 (19.2) |
| Oligodendroglioma, IDH-mutant, 1p/19q codeleted, N (%) | 50 (34.2) |
| Molecular glioblastoma, IDH-wildtype, N (%) | 22 (15) |
| Grade 4 diffuse astrocytoma, IDH-mutant, N (%) | 6 (4.1) |
| Glioblastoma, IDH-wildtype, N (%) | 40 (27.5) |
IDH = isocitrate dehydrogenase.